Trends in the utilization of imaging for upper tract urothelial carcinoma

被引:14
作者
Mohapatra, Anand [1 ]
Vemana, Goutham [2 ]
Bhayani, Sam [1 ]
Baty, Jack [3 ]
Vetter, Joel [1 ]
Strope, Seth A. [1 ]
机构
[1] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA
[2] Urol Associates Houston, Houston, TX USA
[3] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
Upper Tract Urothelial Cancer; Imaging; Diagnosis; Endoscopy; Surgery; TRANSITIONAL-CELL-CARCINOMA; BOLUS MDCT UROGRAPHY; TOMOGRAPHY UROGRAPHY; CT UROGRAPHY; GUIDELINES; OUTCOMES;
D O I
10.1016/j.urolonc.2015.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To evaluate the changes in use of the different imaging modalities for diagnosing upper tract urothelial carcinoma (UTUC) and assess how these changes have affected tumor stage at the time of surgery. Materials and methods: We assessed the Surveillance, Epidemiology, and End Results (SEER) cancer registry and linked Medicare claims data (1992-2009) for 5377 patients who underwent surgery for UTUC. We utilized International Classification of Disease Oncology 3 codes to identify UTUC. International Classification of Disease, ninth Revision, Clinical Modification and Current Procedure Terminology codes identified surgical treatment and imaging modalities. We assessed for use of intravenous pyelography, retrograde pyelography (RGP), computed tomography urography (CTU), magnetic resonance urography (MRU), and endoscopy. For each modality, patients were categorized as having received the modality at least once or not at all. Patient characteristics were compared using chi-squared tests. Usage of imaging modalities and tumor stage was trended using Cochran-Armitage tests. We stratified our data into 2 multivariate logistic regression models to determine the effect of imaging modalities on tumor stage: 1992 to 1999 with all modalities except MRU, and 2000 to 2009 with all modalities. Results: Our patient population was predominantly White males of more than 70 years old. Intravenous pyelography and RGP declined in use (62% and 72% in 1992 vs. 6% and 58% in 2009, respectively) while computed tomography urography, MRU, and endoscopy increased in use (2%, 0%, and 37% in 1992 vs. 44%, 6%, and 66% in 2009, respectively). In both regression analyses, endoscopy was associated with lower-stage tumors. In the 2000 to 2009 model, RGP was associated with lower-stage tumors, and MRU was associated with higher-stage tumors. Finally, our data showed an increasing number of modalities utilized for each patient (1% receiving 4 modalities in 1992 vs. 20% in 2009). Conclusions: We found trends toward the utilization of newer imaging modalities to diagnose UTUC and more modalities per patient. Endoscopy and RGP were associated with smaller tumors, whereas MRU was associated with larger tumors. Further studies are needed to evaluate the utility of the different modalities in diagnosing UTUC. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:236.e23 / 236.e28
页数:6
相关论文
共 50 条
  • [21] Comparison of biopsy devices in upper tract urothelial carcinoma
    Breda, Alberto
    Territo, Angelo
    Sanguedolce, Francesco
    Basile, Giuseppe
    Subiela, Jose D.
    Vila Reyes, Helena
    Mayordomo Ferrer, Olga
    Gaya, Jose M.
    Palou, Joan
    WORLD JOURNAL OF UROLOGY, 2019, 37 (09) : 1899 - 1905
  • [22] Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
    Green, David A.
    Rink, Michael
    Xylinas, Evanguelos
    Matin, Surena F.
    Stenzl, Arnulf
    Roupret, Morgan
    Karakiewicz, Pierre I.
    Scherr, Douglas S.
    Shariat, Shahrokh F.
    JOURNAL OF UROLOGY, 2013, 189 (04) : 1214 - 1221
  • [23] Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma
    Park, Bong Hee
    Jeon, Seong Soo
    KOREAN JOURNAL OF UROLOGY, 2013, 54 (07) : 426 - 432
  • [24] Upper tract urothelial carcinoma: Impact of time to surgery
    Sundi, Debasish
    Svatek, Robert S.
    Margulis, Vitaly
    Wood, Christopher G.
    Matin, Surena F.
    Dinney, Colin P.
    Kamat, Ashish M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (03) : 266 - 272
  • [25] Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?
    Trail, Matthew
    Rahman, Muhammad Sajid Waheed
    Broadhurst, William J.
    Blackmur, James P.
    Sharma, Abhishek
    Chew, Etienne
    O'Donnell, Marie
    Keanie, Julian Y.
    Brush, John
    Taylor, John
    Phipps, Simon
    Thomas, Ben
    Mains, Edward A. A.
    McNeill, S. Alan
    Leung, Steve
    Cutress, Mark L.
    Laird, Alexander
    BJU INTERNATIONAL, 2023, 131 (06) : 755 - 762
  • [26] Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma
    Jinzaki, Masahiro
    Kikuchi, Eiji
    Akita, Hirotaka
    Sugiura, Hiroaki
    Shinmoto, Hiroshi
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (04) : 284 - 298
  • [27] Segmental ureterectomy for upper tract urothelial carcinoma: Two procedures with different indications
    Xylinas, Evanguelos
    Roupret, Morgan
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (08) : 1841 - 1843
  • [28] Secondary bladder cancer after upper tract urothelial carcinoma in the US population
    Kates, Max
    Badalato, Gina M.
    Gupta, Mantu
    McKiernan, James M.
    BJU INTERNATIONAL, 2012, 110 (09) : 1325 - 1329
  • [29] Oncologic surveillance intensity after endoscopic treatment of upper tract urothelial carcinoma
    Basile, Giuseppe
    Gallioli, Andrea
    Martini, Alberto
    Verri, Paolo
    Robalino, Jorge
    Dieguez, Lucia
    Gavrilov, Pavel
    Territo, Angelo
    Uleri, Alessandro
    Gaya, Josep M.
    Algaba, Ferran
    Palou, Joan
    Breda, Alberto
    MINERVA UROLOGY AND NEPHROLOGY, 2024, 76 (01): : 88 - 96
  • [30] Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration
    Hellenthal, Nicholas J.
    Shariat, Shahrokh F.
    Margulis, Vitaly
    Karakiewicz, Pierre I.
    Roscigno, Marco
    Bolenz, Christian
    Remzi, Mesut
    Weizer, Alon
    Zigeuner, Richard
    Bensalah, Karim
    Ng, Casey K.
    Raman, Jay D.
    Kikuchi, Eiji
    Montorsi, Francesco
    Oya, Mototsugu
    Wood, Christopher G.
    Fernandez, Mario
    Evans, Christopher P.
    Koppie, Theresa M.
    JOURNAL OF UROLOGY, 2009, 182 (03) : 900 - 906